OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits
Valwynne Faulkner, Adrienne A. Cox, Shan Goh, et al.
Frontiers in Microbiology (2021) Vol. 11
Open Access | Times Cited: 14
Valwynne Faulkner, Adrienne A. Cox, Shan Goh, et al.
Frontiers in Microbiology (2021) Vol. 11
Open Access | Times Cited: 14
Showing 14 citing articles:
Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development
Liqin Shi, Ruiqi Gu, Jinzhao Long, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Liqin Shi, Ruiqi Gu, Jinzhao Long, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria
Stephanie N. Call, Lauren B. Andrews
Frontiers in Genome Editing (2022) Vol. 4
Open Access | Times Cited: 26
Stephanie N. Call, Lauren B. Andrews
Frontiers in Genome Editing (2022) Vol. 4
Open Access | Times Cited: 26
Harnessing CRISPR interference to resensitize laboratory strains and clinical isolates to last resort antibiotics
Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe
Hongjuan Zhang, Ying Chen, Yu Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2056-2070
Open Access | Times Cited: 11
Hongjuan Zhang, Ying Chen, Yu Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2056-2070
Open Access | Times Cited: 11
Tuberculosis conundrum - current and future scenarios: A proposed comprehensive approach combining laboratory, imaging, and computing advances
S A Merchant, Mohd Javed Saifullah Shaikh, Prakash M. Nadkarni
World Journal of Radiology (2022) Vol. 14, Iss. 6, pp. 114-136
Open Access | Times Cited: 15
S A Merchant, Mohd Javed Saifullah Shaikh, Prakash M. Nadkarni
World Journal of Radiology (2022) Vol. 14, Iss. 6, pp. 114-136
Open Access | Times Cited: 15
CRISPR Interference-Mediated Silencing of the mmpL3 Gene in Mycobacterium smegmatis and Its Impact on Antimicrobial Susceptibility
Yonita Yuliani, Azizah Fitriana Nurul Ilmi, Suthidee Petsong, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 483-483
Open Access | Times Cited: 1
Yonita Yuliani, Azizah Fitriana Nurul Ilmi, Suthidee Petsong, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 483-483
Open Access | Times Cited: 1
Implementation of a mycobacterial CRISPRi platform in Mycobacterium abscessus and demonstration of the essentiality of ftsZ
Rashmi Gupta, Kyle H. Rohde
Tuberculosis (2022) Vol. 138, pp. 102292-102292
Open Access | Times Cited: 6
Rashmi Gupta, Kyle H. Rohde
Tuberculosis (2022) Vol. 138, pp. 102292-102292
Open Access | Times Cited: 6
Harnessing CRISPR-Cas9 as an anti-mycobacterial system
Megha Sodani, Chitra Seetharam Misra, Devashish Rath, et al.
Microbiological Research (2023) Vol. 270, pp. 127319-127319
Open Access | Times Cited: 3
Megha Sodani, Chitra Seetharam Misra, Devashish Rath, et al.
Microbiological Research (2023) Vol. 270, pp. 127319-127319
Open Access | Times Cited: 3
The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis
Nuntita Singpanomchai, Panan Ratthawongjirakul
Scientific Reports (2024) Vol. 14, Iss. 1
Closed Access
Nuntita Singpanomchai, Panan Ratthawongjirakul
Scientific Reports (2024) Vol. 14, Iss. 1
Closed Access
Non-replicative phage particles delivering CRISPR-Cas9 to target major blaCTX-M variants
Naiyaphat Nittayasut, Teerapong Yata, Sunisa Chirakul, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303555-e0303555
Open Access
Naiyaphat Nittayasut, Teerapong Yata, Sunisa Chirakul, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303555-e0303555
Open Access
Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery
Chris Daniel, Sam Willcocks, Sanjib Bhakta
Methods in molecular biology (2024), pp. 23-33
Closed Access
Chris Daniel, Sam Willcocks, Sanjib Bhakta
Methods in molecular biology (2024), pp. 23-33
Closed Access
EfpA is required for regrowth of Mycobacterium tuberculosis following isoniazid exposure
Adam H. Roberts, Christopher Moon, Valwynne Faulkner, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 8
Open Access
Adam H. Roberts, Christopher Moon, Valwynne Faulkner, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 8
Open Access
Harnessing CRISPR interference to re-sensitize laboratory strains and clinical isolates to last resort antibiotics
Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Angelica Frusteri Chiacchiera, Michela Casanova, Massimo Bellato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
EfpA is required for re-growth ofMycobacterium tuberculosisfollowing isoniazid exposure
Adam H. Roberts, Christopher Moon, Valwynne Faulkner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Adam H. Roberts, Christopher Moon, Valwynne Faulkner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
